Medscape www.medscape.com

References for:
Safety and Immunogenicity of Meningococcus Serogroup C Conjugate Vaccine Administered as a Primary or Booster Vaccination to Healthy Four-Year-Old Children

[Pediatr Infect Dis J 21(8):747-753, 2002. © 2002 Lippincott Williams & Wilkins]

  1. English M, MacLennan JM, Bowen-Morris JM, et al. A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants. Vaccine 2001; 19: 1232-8.
  2. MacLennan J, Shackley F, Heath PT, et al. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants. JAMA 2000; 283: 2795-801.
  3. Richmond P, Borrow R, Miller E, et al. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J Infect Dis 1999; 179: 1569-72.
  4. Granoff DM, Maslanka SE, Carlone GM, et al. A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses. Clin Diagn Lab Immunol 1998; 5: 479-85.
  5. Maslanka SE, Gheesling LL, Libutti DE, et al. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays: The Multilaboratory Study Group. Clin Diagn Lab Immunol 1997; 4: 156-67.
  6. STATA Statistical Software: Release 7.0. College Station, TX: Stata Corp., 2001.
  7. Gold R, Lepow ML, Goldschneider I, Gotschlich EC. Immune response of human infants to polysaccharide vaccines of groups A and C Neisseria meningitidis. J Infect Dis 1977; 136 (Suppl): S31-5.
  8. MacLennan J, Obaro S, Deeks J, et al. Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunization during early childhood. Vaccine 1999; 17: 3086-93.
  9. MacDonald N, Halperin SA, Law BJ, Forrest B, Danzig LE, Granoff DM. Induction of immunologic memory by conjugated vs. plain meningococcal C polysaccharide vaccine in toddlers. JAMA 1998; 280: 1685-9.
  10. Granoff DM, Gupta RK, Belshe RB, Anderson EL. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination. J Infect Dis 1998; 178: 870-4.
  11. Richmond P, Kaczmarski E, Borrow R, et al. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J Infect Dis 2000; 181: 761-4.
  12. MacDonald NE, Halperin SA, Law BJ, Danzig LE, Granoff DM. Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine? JAMA 2000; 283: 1826-7.
  13. Pulendran B, Kannourakis G, Nouri S, Smith KGC, Nossal GJV. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature 1995; 375: 331-4.
  14. MacLennan J, Obaro S, Deeks J, et al. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy. J Infect Dis 2001; 183: 97-104.
  15. Santos G, Wacknov B, Borrow R, et al. Comparison of bactericidal assays used to measure immunological responses to vaccines developed against Neisseria meningitidis serogroup C. In: 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, September 17 to 20, 2000. Washington, DC: American Society for Microbiology, 2000:238.
  16. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus: I. The role of humoral antibodies. J Exp Med 1969:1307-23.
  17. Borrow R, Andrews N, Goldblatt D, Miller E. Serologic basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect Immun 2001; 69: 1568-73.
  18. Anderson P, Ingram DL, Pichichero ME, Peter G. A high degree of natural immunologic priming to the capsular polysaccharide may not prevent Haemophilus influenzae type b meningitis. Pediatr Infect Dis J 2000; 19: 589-91.
  19. Holmes SJ, Granoff DM. The biology of Haemophilus influenzae type b vaccination failure. J Infect Dis 1992; 165 (Suppl): S121-8.
  20. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus: II. Development of natural immunity. J Exp Med 1969:1327-48.
  21. Borrow R, Southern J, Andrews N, et al. Comparison of antibody kinetics following meningococal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controls. Vaccine 2001; 19: 3043-50.
  22. DeVoe IW. The meningococcus and mechanisms of pathogenicity. Microbiol Rev 1982; 46: 162-90.
  23. Ramsay ME, Andrews N, Kaczmarski EB, Miller E. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 2001; 357: 195-6.